Fundraising for a cure

Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them



Pancreatic Neuroendocrine Tumours (pNET) are increasing in incidence(1), (2).  They carry a relatively poor prognosis compared to other NETs, particularly when hepatic metastasis are present.  We have a proactive management strategy that is agreed in a weekly NET MDT.  We have studied our outcomes and determined survival at 1, 3 & 5 years and compared our outcomes to previously published data.  The data is on our whole cohort not on selected treatments and irrespective of age, fitness, age or co-morbidities.  Click on the link below for full presentation.

Aggressive multi-modality treatment of Pancreatic Neuroendocrine Tumours

How the money raised is spent

See all stories